Piper Sandler lowered the firm’s price target on Colgate-Palmolive (CL) to $92 from $96 and keeps an Overweight rating on the shares. The firm notes the company’s exposure to higher resin and other oil derivative costs is about 9% of COGS, a figure that could go higher if oil costs remain elevated.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $92 from $100 at Wells Fargo
- Colgate-Palmolive price target lowered to $98 from $100 at UBS
- TD downgrades Colgate-Palmolive on higher oil-based input costs
- Colgate-Palmolive downgraded to Hold from Buy at TD Cowen
- Colgate-Palmolive upgraded to Buy from Hold at Deutsche Bank